Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kala Bio Inc (KALA)

Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kala Bio Inc 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 USA

www.kalarx.com Employees: 43 P: 781-996-5252 F: 781-642-0399

Description:

KALA BIO is a clinical-stage biopharmaceutical company. It focused on the research, development and commercialization of therapies for rare and severe diseases of the eye. The company' s lead product candidate consists KPI-012. KALA BIO, formerly known as Kala Pharmaceuticals Inc., is based in ARLINGTON, Mass.

Key Statistics

Overview:

Market Capitalization, $K 29,643
Enterprise Value, $K 17,043
Shares Outstanding, K 4,610
Annual Sales, $ 0 K
Annual Net Income, $ -42,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,950 K
EBIT, $ -41,150 K
EBITDA, $ -39,590 K
60-Month Beta -2.13
% of Insider Shareholders 8.32%
% of Institutional Shareholders 24.61%
Float, K 4,227
% Float 91.68%
Short Volume Ratio 0.69

Growth:

1-Year Return 1.23%
3-Year Return -93.05%
5-Year Return -96.92%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 86.01%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.93 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -12.47
EPS Growth vs. Prev Qtr 38.92%
EPS Growth vs. Prev Year 43.40%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 10/21/22

KALA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -448.61%
Return-on-Assets % -69.37%
Profit Margin % 0.00%
Debt/Equity 5.80
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.34
Book Value/Share 1.49
Interest Coverage -6.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar